ctrl K

Watchlist Price Alert

Horizon Therapeutics Publ... (HZNP)

NASDAQ: HZNP · Real-Time Price · USD

116.30

0.00 (0.00%)

At close: Jan 16, 2025, 9:00 PM

Horizon Therapeutics Public Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	3.63B	3.23B	2.2B	1.3B	1.21B	1.06B	981.12M
Cost of Revenue	920.2M	794.51M	532.7M	362.18M	422.32M	546.27M	393.27M
Gross Profit	2.71B	2.43B	1.67B	937.85M	785.25M	509.96M	587.85M
Operating Income	617.41M	543.13M	490.03M	126.61M	2.39M	-392.37M	-147.17M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	526.94M	462.83M	401.64M	-20.22M	-119.15M	-513.27M	-228.09M
Net Income	521.48M	534.49M	389.8M	573.02M	-74.19M	-410.53M	-166.83M
Selling & General & Admin	1.54B	1.45B	973.23M	697.11M	692.49M	677.36M	608.31M
Research & Development	437.96M	431.99M	209.36M	103.17M	82.76M	224.96M	60.71M
Other Expenses	-5.57M	1.79M	3.39M	-944K	346K	588K	6.7M
Operating Expenses	1.98B	1.88B	1.18B	800.28M	775.25M	902.33M	669.01M
Interest Expense	83.71M	81.06M	59.62M	87.09M	121.69M	126.52M	86.61M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	320.37M
Cost & Expenses	2.9B	2.67B	1.72B	1.16B	1.2B	1.45B	1.06B
Income Tax Expense	5.45M	-71.66M	11.85M	-593.24M	-44.96M	-102.75M	-61.25M
Shares Outstanding (Basic)	229.11M	225.55M	215.31M	205.22M	166.16M	163.12M	160.7M
Shares Outstanding (Diluted)	235.24M	235.68M	215.31M	205.22M	166.16M	163.12M	160.7M
EPS (Basic)	2.28	2.37	1.91	3.13	-0.45	-2.52	-1.04
EPS (Diluted)	2.22	2.27	1.81	2.90	-0.45	-2.52	-1.04
EBITDA	1.11B	909.04M	767.98M	373.79M	286.08M	-108.37M	147.37M
EBIT	610.64M	543.89M	461.26M	66.86M	2.55M	-386.75M	-141.47M
Depreciation & Amortization	497.25M	365.91M	277.96M	247.18M	275.73M	283.42M	221.84M